---
layout: default
title: Publications
weight: 4
--- 

>An up-to-date list can be found on [pubmed](http://www.ncbi.nlm.nih.gov/pubmed?term=artavanis-tsakonas%20k%5BAuthor%5D)

**Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity.**  
Morrow ME, Kim MI, Ronau JA, Sheedlo MJ, White RR, Chaney J, Paul LN, Lill MA, Artavanis-Tsakonas K, Das C.  
Biochemistry. 2013 Apr 25.

**How helminths use excretory secretory fractions to modulate dendritic cells.**  
White RR, Artavanis-Tsakonas K.  
Virulence. 2012 Nov 15;3(7).

**Characterisation of the Trichinella spiralis deubiquitinating enzyme, TsUCH37, an evolutionarily conserved proteasome interaction partner.**  
White RR, Miyata S, Papa E, Spooner E, Gounaris K, Selkirk ME, Artavanis-Tsakonas K.  
PLoS Negl Trop Dis. 2011 Oct;5(10):e1340.

**The tetraspanin CD82 is specifically recruited to fungal and bacterial phagosomes prior to acidification.**  
Artavanis-Tsakonas K, Kasperkovitz PV, Papa E, Cardenas ML, Khan NS, Van der Veen AG, Ploegh HL, Vyas JM.  
Infect Immun. 2011 Mar;79(3):1098-106.

**Structural studies and characterization of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3.**  
Artavanis-Tsakonas K, Weihofen WA, Antos JM, Coleman BI, Comeaux CA, Duraisingh MT, Gaudet R, Ploegh HL.  
J Biol Chem. 2010, Feb 26;285(9):6857-66.

**Substrate ﬁltering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations.**  
Popp MW,  Artavanis-Tsakonas K, Ploegh HL.  
J Biol Chem. 2009, Feb 6;284(6):3593-602.

**Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.**  
Walters BJ, Campbell SL, Chen PC, Taylor AP, Schroeder DG, Dobrunz LE, Artavanis-Tsakonas K, Ploegh HL, Wilson JA, Cox GA, Wilson SM.  
Mol Cell Neurosci. 2008 Dec;39(4): 539-48.

**Tubulation of Class II MHC compartments is microtubule-dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells.**  
Vyas JM, Kim Y, Artavanis-Tsakonas K, van der Veen A., Love JC, Ploegh HL.  
J Immunol. 2007, 178(11):7199-210.

**Apicomplexan UCH-L3 retains dual speciﬁcity for ubiquitin and Nedd8 throughout evolution.**  
Frickel EM, Quesada V, Muething L, Gubbels MJ, Spooner E, Ploegh H, Artavanis-Tsakonas K.  
Cell Microbiol. 2007, 9(6):1601-10.

**Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidiﬁcation.**  
Artavanis-Tsakonas K, Love JC, Ploegh HL and Vyas JM.  
Proc Natl Acad Sci. 2006, 103(43):15945-50.

**Identiﬁcation by functional proteomics of a deubiquitinating/deNeddylating enzyme in Plasmodium falciparum.**  
Artavanis-Tsakonas K, Misaghi S, Comeaux CA, Catic A, Spooner E, Duraisingh MT, Ploegh HL.  
Mol Microbiol. 2006, 61(5):1187-95.

**Uninfected erythrocytes inhibit P. falciparum-induced cellular immune responses in whole blood assays.**  
Struik SS, Omer FM, Artavanis-Tsakonas K and Riley EM.  
Blood. 2004, 103(8):3084-92.

**Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.**  
Artavanis-Tsakonas K, Eleme K, Davis DM and Riley EM.  
J Immunol. 2003, 171(10):5396-405.

**The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.**  
Artavanis-Tsakonas K, Tongren JE and Riley EM.  
Clin Exp Immunol, 2003, 133(2):145-52.

**Innate immune responses to Plasmodium falciparum malaria: early IFN-γ production is derived from NK cells and is preferentially induced by live rather than dead parasites.**  
Artavanis-Tsakonas K and Riley EM.  
J Immunol, 2002, 169: 2956-2963.
